These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 3131464
1. Induction of interferon-gamma and tumor necrosis factor in ascites of a patient with ovarian cancer by OK-432. Mori H, Itoh N, Shiraki S, Tamaya T. Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):497-8. PubMed ID: 3131464 [No Abstract] [Full Text] [Related]
2. Mechanism of induction of endogenous tumor necrosis factor in ascites of ovarian cancer patients by OK-432, a streptococcal preparation. Mori H, Itoh N, Tamaya T. Immunopharmacol Immunotoxicol; 1989 Apr; 11(1):33-53. PubMed ID: 2503555 [Abstract] [Full Text] [Related]
3. Induction of endogenous cytokines in ascites of patients with ovarian cancer by OK-432, a streptococcal preparation. Mori H, Itoh N, Yamada Y, Tamaya T. Asia Oceania J Obstet Gynaecol; 1989 Sep; 15(3):281-9. PubMed ID: 2512905 [Abstract] [Full Text] [Related]
4. Induction of endogenous tumor necrosis factor by OK-432 in ovarian cancer patients with ascites. Mori H, Itoh N, Yamada Y, Tamaya T. Biotherapy; 1989 Sep; 1(3):123-31. PubMed ID: 2518374 [Abstract] [Full Text] [Related]
5. Production of tumor necrosis factor (TNF) by monocytes from cancer patients and healthy subjects induced by OK-432 in vitro, and its augmentation by human interferon gamma. Sekimoto M, Kokunai I, Shimano T, Kobayashi T, Takeda T, Haruna N, Yamamoto A, Mori T. J Clin Lab Immunol; 1988 Nov; 27(3):115-20. PubMed ID: 3150012 [Abstract] [Full Text] [Related]
6. [Enhancing effects on interferon-gamma production by combination of OK-432 and interferon-alpha in patients with head and neck cancer]. Sugiyama M, Morisaki N, Konishi K, Go K, Sugita M, Nakai Y. Gan To Kagaku Ryoho; 1984 Oct; 11(10):2200-6. PubMed ID: 6435540 [Abstract] [Full Text] [Related]
7. Augmentation of cytotoxicity of lymphokine activated killer cells on ovarian tumor cells by various biological response modifiers. Nio Y, Zighelboim J, Berek JS, Bonavida B. Anticancer Res; 1990 Oct; 10(2A):441-6. PubMed ID: 2346317 [Abstract] [Full Text] [Related]
8. [Induction of mouse peritoneal cytotoxic factor by OK-432. (3). Comparison between LPS and OK-432 as eliciting agents]. Yamamoto A, Nagamuta M, Usami H, Sugawara Y, Nishii Y, Suzuki S, Watanabe N, Niitsu Y, Urushizaki I. Gan To Kagaku Ryoho; 1986 Jul; 13(7):2419-24. PubMed ID: 3729496 [Abstract] [Full Text] [Related]
9. [Induction of a cytotoxic factor into the peritoneal fluid (PCF) by OK-432. II. Physicochemical and immunological characteristics of PCF]. Nagamuta M, Yamamoto A, Usami H, Sugawara Y, Nishii Y, Watanabe N, Niitsu Y, Urushizaki I. Gan To Kagaku Ryoho; 1986 Jul; 13(7):2358-62. PubMed ID: 3488030 [Abstract] [Full Text] [Related]
10. [Production of a cytotoxic factor in mouse peritoneal fluid by OK-432, a streptococcal preparation]. Yamamoto A, Nagamuta M, Usami H, Sugawara Y, Watanabe N, Niitsu Y, Urushizaki I. Gan To Kagaku Ryoho; 1986 May; 13(5):1905-10. PubMed ID: 3707150 [Abstract] [Full Text] [Related]
11. Induction of tumor necrosis factor by administration of OK-432 in cancer patients. Kokunai I, Shimano T, Sekimoto K, Takeda T, Kobayashi T, Yayoi E, Yamamoto A, Mori T. J Clin Lab Immunol; 1986 Dec; 21(4):169-71. PubMed ID: 3560194 [Abstract] [Full Text] [Related]
12. [Effect of malignant ascitic fluids and OK-432 on the induction of LAK activity in peripheral blood mononuclear cells of gynecological cancer patients]. Kanaoka Y, Umesaki N. Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jun; 43(6):611-8. PubMed ID: 1856521 [Abstract] [Full Text] [Related]
13. Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial origin. Satoh M, Inagawa H, Shimada Y, Soma G, Oshima H, Mizuno D. J Biol Response Mod; 1987 Oct; 6(5):512-24. PubMed ID: 2445926 [Abstract] [Full Text] [Related]
14. Impaired induction of type II interferon in tumor-bearing mice. Matsubara S, Suzuki M, Ishida N. Cancer Res; 1980 Mar; 40(3):873-6. PubMed ID: 6162555 [Abstract] [Full Text] [Related]
15. [TNF induction in the serum and ascites of a gastric cancer patient treated with OK-432]. Neda H, Watanabe N, Sone H, Yamauchi N, Niitsu Y, Urushizaki I. Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):593-7. PubMed ID: 3954382 [Abstract] [Full Text] [Related]
16. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment. Yamaguchi Y, Ohshita A, Kawabuchi Y, Hihara J, Miyahara E, Noma K, Toge T. Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836 [Abstract] [Full Text] [Related]
17. [Antitumor effect of OK-432 (1)--antitumor effect of OK-432 induced interferon-gamma (IFN gamma)]. Saito M, Yamaguchi T, Aonuma E, Noda T, Edina T, Ishida N. Gan To Kagaku Ryoho; 1982 Nov; 9(11):2031-7. PubMed ID: 6820888 [Abstract] [Full Text] [Related]
18. [The effect of endogenous tumor necrosis factor (TNF)-induction therapy in the model of VX-2 ovarian carcinoma in the rabbit]. Hirata S. Nihon Sanka Fujinka Gakkai Zasshi; 1990 Nov; 42(11):1477-83. PubMed ID: 2273301 [Abstract] [Full Text] [Related]
19. Generation of activated killer-like cells by OK-432-mediated production of interleukin 1, interleukin 2, and interferon-gamma in vitro. Ujiie T. Jpn J Exp Med; 1987 Dec; 57(6):333-8. PubMed ID: 3131563 [Abstract] [Full Text] [Related]
20. [Changes of cytokine levels in ascitic fluid after intraperitoneal administration of OK-432 or CDDP]. Terashima M, Takagane A, Abe K, Kuboi M, Asahi H, Saito K. Gan To Kagaku Ryoho; 1994 Sep; 21(13):2326-9. PubMed ID: 7944471 [Abstract] [Full Text] [Related] Page: [Next] [New Search]